PubMed HealthSearch

Biomedical subjects

H R Nitze

Publications and source records attributed to H R Nitze.

At least 19 recordsLinked to original sources

[Peritumor lymph flow].

The peritumoural lymph current of 28 tumours of the head and the neck was analysed by using colloidal 198Au. In 10 cases a mostly unilateral, sometimes also a bilateral, flow of the radiomarker into the lymphatic system was seen. Whereas the flow was independent of the stage, it depended on the localisation of the tumour, the tonsillar and retrolingual regions being more effectively perfused than the larynx. If there was a detectable lymph current, clinical and histological metastases were often present in the lymph nodes. The peritumoural lymph current is an important factor in the lymphogenous formation of metastases.

Aged

[Post-laryngectomy vocal rehabilitation with a tracheophypopharyngeal shunt (author's transl)].

Oesophageal speech is the accepted method of post-laryngectomy speech rehabilitation, but still has a high failure rate. Among the different surgical procedures that create a tracheo-oesophageal fistula the method of Komorn based on a concept of Conley appears to have the greatest theoretical advantages. In this procedure a fistula is created with its inferior opening into the oesophagus and its superior opening into the trachea. Komorn's technique has been utilized in a modified form in 12 patients and in 6, because of wound problems, useful speech was not achieved. Five patients have achieved excellent speech without difficulty.

Glottis

[New aspects in the treatment of malignancy of the ear, nose, and throat (author's transl)].

The management of malignancy continues to change, and the basis of this change is improvement in diagnostic and therapeutic tech techniques and the search for new therapeutic principles. Examples of each group are given although their practical value is uncertain. They are important because they attempt to make methods of basic research in tumour biology applicable to clinical medicine.

Antineoplastic Agents